Spironolactone and Desowen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 6 people who take Spironolactone and Desowen. Common interactions include cough among females, and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people who take Spironolactone and Desowen have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 25, 2023

6 people who take Spironolactone and Desowen together, and have interactions are studied.


What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is used in acne. Currently, eHealthMe is studying from 113,577 Spironolactone users.

What is Desowen?

Desowen has active ingredients of desonide. Currently, eHealthMe is studying from 500 Desowen users.

Number of Spironolactone and Desowen reports submitted per year:

Spironolactone and Desowen drug interactions.

Common Spironolactone and Desowen drug interactions by gender *:

female:

  1. Cough
  2. Hyperparathyroidism secondary
  3. Malaise
  4. Mesangioproliferative glomerulonephritis
  5. Nephrogenic anaemia
  6. Renal failure
  7. Activities of daily living impaired
  8. Autonomic nervous system imbalance
  9. Chronic kidney disease

male:

  1. Cardiac failure congestive
  2. Dizziness (excl vertigo)
  3. Hyperkalaemia
  4. Myocardial infarction
  5. Renal failure acute
  6. Rhabdomyolysis
  7. Syncope

Common Spironolactone and Desowen drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Mesangioproliferative glomerulonephritis
  2. Nephrogenic anaemia
  3. Renal failure
  4. Chronic kidney disease
  5. Hyperparathyroidism secondary

50-59:

n/a

60+:

  1. Cardiac failure congestive
  2. Cough
  3. Dizziness (excl vertigo)
  4. Hyperkalaemia
  5. Myocardial infarction
  6. Renal failure acute
  7. Rhabdomyolysis
  8. Syncope

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and Desowen?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Spironolactone side effects:

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Spironolactone interactions:

Browse all interactions between Spironolactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone and desonide (the active ingredients of Spironolactone and Desowen, respectively), and Spironolactone and Desowen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Spironolactone and Desowen.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: